Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients

Atherosclerosis

Volumn 136, Issue 2, 1998, Pages 281-287

  Ichikawa, Koujiro ^a   Yoshinari, Mototaka ^a   Iwase, Masanori ^a   Wakisaka, Masanori ^a   Doi, Yasufumi ^a   Iino, Kenzo ^a   Yamamoto, Misao ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Advanced glycosylation end products; Atherosclerosis; Macrophage; Tissue factor

Indexed keywords

ALBUMIN; CATALASE; MESSENGER RNA; PROBUCOL; THROMBOPLASTIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; GLYCOSYLATION; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; MACROPHAGE; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOSIS;

ALBUMINS; ANTIOXIDANTS; CATALASE; CELLS, CULTURED; DIABETES MELLITUS; FLOW CYTOMETRY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LEUKEMIA, EXPERIMENTAL; MACROPHAGES; MONOCYTES; PROBUCOL; RECEPTORS, IMMUNOLOGIC; THROMBOPLASTIN; TUMOR CELLS, CULTURED;

EID: 0032007011     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00221-9     Document Type: Article

References (36)

1. Pyoräla K., Laakso M., Üusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 3:1987;463-524.
2. Kunjathoor V.V., Wilson D.L., LeBoeuf R.C. Increased atherosclerosis in Streptozotocin-induced diabetic mice. J Clin Invest. 97:1996;1767-1773.
3. Krolewski A.S., Kosinski E.J., Warram J.H., Leland O.S., Busick E.J., Asmal A.C., Rand L.I., Christlieb A.R., Bradley R.F., Kahn C.R. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol. 59:1987;750-755.
4. Nakamura Y., Horii Y., Nishino T., Shiiki H., Sakaguchi Y., Kagoshima T., Dohi K., Makita Z., Vlassara H., Bucala R. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol. 143:1993;1649-1656.
5. Monnier V., Kohn R., Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA. 81:1984;583-587.
6. Brownlee M.H., Vlassara H., Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med. 101:1984;527-537.
7. Brownlee M.H., Vlassara H., Cerami A. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Med. 318:1988;1315-1321.
8. Esposito C., Gerlach H., Brett J., Stern D., Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med. 170:1989;1387-1407.
9. Bajaj S.P., Rapaport S.I., Brown S.F. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem. 256:1981;253-259.
10. Broze G.J., Leykam J.E., Schwarts B.D., Miletich J.P. Purification of human brain tissue factor. J Biol Chem. 260:1985;10917-10920.
11. Mertens K., Bertina R.M. Pathways in the activation of human coagulation factor X. Biochem J. 185:1980;647-658.
12. Wilcox J.N., Smith K.M., Schwartz S.M., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 86:1989;2839-2843.
13. Ichikawa K., Nakagawa M., Hirano K., Sueishi K. The localization of tissue factor and apolipoprotein(a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition. Pathol Res Pract. 192:1996;224-232.
14. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
15. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C.E., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 267:1992;14998-15004.
16. Luther T., Flossel C., Hietschhold V., Koslowski R., Muller M. Flow cytometric analysis of tissue factor (TF) expression on stimulated monocytes-comparison to procoagulant activity of mononuclear blood cells. Blut. 61:1990;375-378.
17. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 269:1994;9889-9897.
18. Vlassara H., Brownlee M., Manogue K.R., Dinarello C.A., Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science. 240:1988;1546-1548.
19. Radoff S., Vlassara H., Cerami A. Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified non-enzymatically by advanced glycosylation end products. Arch Biochem Biophys. 263:1988;418-423.
20. Narahara N., Enden T., Wiiger M., Prydz H. Polar expression of tissue factor in human umbilical vein endothelial cells. Arterioscler Thromb. 14:1994;1815-1820.
21. Schmidt A.M., Mora R., Cao R., Yan S.D., Brett J., Ramakrishnan R., Tsang T.C., Simionescu M., Stern D. The endothelial cell binding site for advanced glycation end products consists of a complex: An integral membrane protein and a lactoferrin-like polypeptide. J Biol Chem. 269:1994;9882-9888.
22. Vlassara H., Li Y.M., Imani F., Wojciechowicz D., Yang Z., Liu F.T., Cerami A. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med. 6:1996;634-646.
23. Baeuerle P. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta. 1072:1991;63-80.
24. Schreck R., Rieber P., Baeuerle P. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
25. Mackman N., Brand K., Edgington T.S. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med. 174:1991;1517-1526.
26. Nemerson Y. Tissue factor and hemostasis. Blood. 71:1988;1-8.
27. Ishida T., Tanaka K. Effects of fibrin and fibrinogen degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis. 44:1982;161-174.
28. Smith E.B. Fibrinogen, fibrin and fibrin degradation productions in relation to atherosclerosis. Clin Haematol. 15:1986;353-370.
29. Vlassara H., Fuh H., Makita Z., Krungkrai S., Cerami A., Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA. 89:1992;12043-12047.
30. Kirstein M., Brett J., Radoff S., Ogawa S., Stern D., Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA. 87:1990;9010-9014.
31. Makita Z., Vlassara H., Cerami A., Bucala R. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem. 267:1992;5133-5138.
32. Hayase F., Nagaraj R.H., Miyata S., Njoroge F.G., Monnier V.M. Aging of proteins: immunological detection of glucose derived pyrrole formed during Maillard reaction in vivo. J Biol Chem. 264:1989;3758-3764.
33. Makita Z., Radoff S., Rayfield E.J., Yang Z., Skolnik E., Delaney V., Friedman E.A., Cerami A., Vlassara H. Clinical assessment and significance of advanced glycation in patients with diabetic nephropathy. New Engl J Med. 325:1991;836-842.
34. Borch-Johnsen K., Kreiner S. Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J. 294:1978;1651-1654.
35. Lindner A., Charra B., Sherrard D.J., Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. New Engl J Med. 290:1974;697-701.
36. Almus F.E. Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin. Blood. 77:1991;1256-1262.